Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Jan 22 2021
Published Jan 22 2021
4 min read

Press Release Jan 22 2021

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 22, 2021, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg".

View Attachment